Patent · US Active

Method of administering lactitol to reduce plasma concentration of lactitol

US10806743B1 · kind B1 · utility

0Cited by

13References

21Claims

0Family size

Inventors

Mark Cleveland · Norwell, US
Robert Raleigh · Pembroke, US
Russell W. Pelham · Weymouth, US

Key dates

Filing date	May 12, 2017
Grant date	Oct 20, 2020
Priority date	—
Expiry date	May 12, 2037

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K47/26
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed herein are formulations comprising lactitol for the treatment of chronic idiopathic constipation. As disclosed herein, the formulations are administered after or during a meal to improve the pharmacokinetics of the formulation. In particular, administration of the formulation after or during a meal decreases the absorption of lactitol and reduces the AUC.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.